Dingzhi Huang

机构：Tianjin Medical University Cancer Institute and Hospital, Taichung Veterans General Hospital

发表论文 14 篇 · 总被引 55 次 · h-index 4

代表论文

• Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B) (2025 · Journal of Clinical Oncology · 被引 17)
• Abstract CT030: Phase I study of IBI351 (GFH925) monotherapy in patients with advanced solid tumors: Updated results of the phase I study (2023 · Cancer Research · 被引 13)
• AKR1C3 promotes progression and mediates therapeutic resistance by inducing epithelial-mesenchymal transition and angiogenesis in small cell lung cancer (2024 · Translational Oncology · 被引 9)
• Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study (2025 · Journal of Thoracic Oncology · 被引 3)
• Author Correction: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis (2023 · Nature Communications · 被引 3)
• [Corrigendum] miR‑370 regulates cell proliferation and migration by targeting EGFR in gastric cancer (2022 · Oncology Reports · 被引 2)